Clinician Decision Support Can Reduce Unspecified Testing in Primary Care
By Elana Gotkine HealthDay Reporter
MONDAY, Feb. 5, 2024 -- For older primary care patients, clinician decision support can reduce unspecified testing compared with traditional case-based education alone, according to a study published online Feb. 6 in the Annals of Internal Medicine.
Stephen D. Persell, M.D., M.P.H., from the Northwestern University Feinberg School of Medicine in Chicago, and colleagues examined the effect of clinician decision support redirecting attention to harms and engaging social and reputational concerns on overuse in older patients from 60 primary care internal medicine, family medicine, and geriatrics practices. The analyses compared behavioral science-informed, point-of-care, clinical decision support tools plus brief case-based education (187 clinicians from 30 clinics) with brief case-based education alone (187 clinicians from 30 clinics).
The researchers found that after 18 months, the intervention group had lower adjusted difference-in-differences in annual rates (per 100 patients) of prostate-specific antigen testing, unspecified urine testing, and diabetes overtreatment compared with the education-only group (−8.7, −5.5, and −1.4, respectively). No increase in emergency care related to urinary tract infections or hyperglycemia was seen. Among previously overtreated diabetes patients, a hemoglobin A1c >9.0 percent was more common with the intervention (adjusted difference-in-differences, 0.47 per 100 patients).
"These findings suggest that point-of-care behaviorally informed interventions can reduce overtesting and overuse among older patients of primary care clinicians while preserving clinician discretion," the authors write.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted February 2024
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.